Authors


David Berman, MD, PhD

Latest:

Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial

David Berman, MD, PhD, discusses signs of dose-dependent viral control and reduction in active HIV reservoir in Phase 1/2 STRIVE trial data.


Nilu Goonetilleke, LLBHons, BScHons, PhD

Latest:

The CM Study: Bivalent HIV Vaccine Induces Stronger T Cell Responses in People with HIV on ART

Nilu Goonetilleke, LLBHons, BScHons, PhD, presents findings showing the bivalent HIVconsvX vaccine targets both Mosaic-1 and Mosaic-2, resulting in broader immune responses.


Leslie McGorman, MPPA

Latest:

Political and Social Barriers to Ending the HIV Epidemic

Learning about these barriers is the first step to overcoming them.


Timothy Gauthier, PharmD, BCPS, BCIDP

Latest:

A Passion for Infectious Disease Education and Communication

In our latest podcast, Tim Gauthier, PharmD, BCPS, BCIDP, discusses all things pathogens and antibiotics. He also details the opportunities presented for antimicrobial stewardship when it combines diagnostics and treatment duration.


Alemnew Dagnew, MD, MSc, MVPCD, MPH, FRSPH

Latest:

A Late-Stage Tuberculosis Vaccine is Making its Way Through Clinical Trials

Monday is World Tuberculosis (TB) Day, and a vaccine developed by the Gates Medical Research Institute is being studied in a phase 3 trial. If approved, the vaccine could potentially prevent pulmonary TB in adults and adolescents.


Christina Yen, MD

Latest:

CRAB-By No More?

Understanding the potential and limitations of new Acinetobacter baumannii active therapies.


Kevin Kavanagh, MD

Latest:

A Comparative Analysis Show Distinct Severity of COVID-19 vs Influenza

Results of a study by Yan Xie and colleagues highlight the severe impact of COVID-19, with higher death rates, increased risks of long-term complications, and greater infectivity compared to seasonal influenza.


Uzma Syed, MD, DO

Latest:

Addressing Antimicrobial Resistance in Women

Uzma Syed, MD, DO discussed how various factors increase women’s susceptibility to AMR, the importance of policies, and the need for culturally specific education and advocacy to improve health outcomes.


Gordon Ramage, BSc, PhD

Latest:

Fungal Biofilm-Related Diseases: Diagnosis, Treatment, and Emerging Challenges

Professor Gordon Ramage, BSc, PhD, discusses the increasing impact of fungal biofilms, new treatment options, and the need for enhanced detection methods.



Amanda M. Casto, MD, PhD

Latest:

Analyzing Household Transmission of COVID-19

At ID Week 2024, an investigator, Amanda M. Casto, MD, PhD, discusses her work on the CASCADIA study, which examined infection rates in this setting, and how it challenged assumptions that there is likely a singular carrier bringing viruses into homes.


Caryn Fenner

Latest:

Timeline for mRNA Vaccine Development for Rift Valley Fever

Caryn Fenner and Petro Terblanche outline Afrigen's clinical trial plans, local partnerships, and vaccine pipeline.


Shaun Holt

Latest:

Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential

The ongoing H5N1 avian flu outbreak has severely impacted U.S. poultry and dairy industries, prompting a $1 billion USDA response strategy that includes biosecurity, vaccination research, and innovation funding. With growing concern over viral mutations affecting humans and livestock, rapid, field-based diagnostic tools offer critical support in accelerating detection and containment efforts.


William Schaffner, MD

Latest:

Federal Government Changes Course Again on COVID-19 Vaccine Policy

After the leaders of the NIH, FDA, and HHS made an announcement stating that both pregnant women and children were going to be taken off the COVID-19 immunization schedule, they decided to offer a new designation for the latter group, making it a shared decision between providers and patients.


Ryan Mynatt, PharmD, BCPS

Latest:

Tricky Infusion Issues and Potential Solutions: OPAT Edition

Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.


Harmony Garges, MD, MPH

Latest:

Apretude PrEP Shows High Efficacy, Safety in Diverse Studies

New data at CROI 2025 shows zero cases of HIV acquisition reported with Apretude (cabotegravir long-acting (CAB LA) for PrEP in varied clinical settings and populations in 2 implementation studies in the US and Brazil.


Deema Abdelrahman, PharmBSc, BCIDP

Latest:

Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.


Evelyn Wu, MD

Latest:

Expanding Tick-Borne Disease Trends in New Jersey

Evelyn Wu, MD, reveals a rise in tick-borne diseases in New Jersey over the past two decades and correlations with the influence of warming climate conditions.


Nicole Bradley, PharmD, BCPS, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Stephen Pagkalinawan, MD

Latest:

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Cytomegalovirus Infection

There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.



Esther Y. Bae, PharmD, BCIDP

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


John M. McLaughlin, PhD

Latest:

Evaluating the Efficacy of Paxlovid in High-Risk Patients with Pre-Existing Immunity

John McLaughlin, PhD, examines high-risk individuals with prior SARS-CoV-2 immunity and presents that Paxlovid reduces the risk of hospitalization, death, and severe symptoms, highlighting its ongoing value for high-risk patients in a post-peak pandemic landscape.


Dianne Nguyen, MD

Latest:

Vowst Maintains Consistent Safety Profile in rCDI Patients With Comorbidities

At MAD-ID, Dianne Nguyen, MD, shares Phase 3 data showing consistent tolerability of the microbiome therapy across high-risk patient populations


Lea Monday, MD, PharmD

Latest:

The Escalating Challenges of Gram-Resistant Organisms: The Role of Cefiderocol

Clinical trial and real-world data, including the PROVE study, support its role as an effective and carbapenem-sparing therapy for serious infections, though outcomes vary depending on pathogen and infection type.


Ali Hassan, PharmD

Latest:

Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIV

Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.



Freda Kreier

Latest:

Internal Tremors: Adding to the List of Long COVID Symptoms

Internal tremors are a newly recognized and troubling symptom of Long COVID, experienced by over one-third of participants in a Yale-based study


Seung Ha, PharmD

Latest:

Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.


Nicholas Rebold, PharmD, BCIDP, AAHIVP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.

© 2025 MJH Life Sciences

All rights reserved.